Sign In
Buy ADC
$76.32
-0.590 (-0.767%)
At Close: Aug 04, 2026
Updated Phase 2 data evaluating ZYNLONTA® as a monotherapy demonstrate overall response rate (ORR) of 85% and complete response (CR) rate of 69% CR maintained in 17 of 18 patients who achieved CR, wi
The Inflation That Wasn't
09:00am, Sunday, 15'th Jun 2025
US equity markets retreated from the cusp of record-highs this week as encouraging inflation data showing surprisingly muted tariff-related inflation was spoiled by a sudden escalation in Middle East
Why I Will Never Retire
08:05am, Saturday, 14'th Jun 2025
Retirement is often misunderstood; rather than a cliff, it should be an off-ramp to more meaningful, flexible work and personal fulfillment. Research shows that abrupt retirement can negatively impact
ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028
06:45am, Thursday, 12'th Jun 2025
LAUSANNE, Switzerland , June 12, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced th
ADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 Congress
06:30am, Thursday, 12'th Jun 2025
ZYNLONTA® in combination with glofitamab (COLUMVI®) in patients with r/r DLBCL demonstrated clinically meaningful benefit with overall response rate (ORR) of 93.3% and a complete response (CR) rate
Compound Your Retirement With These 5 Monthly Dividend REITs
07:00am, Wednesday, 11'th Jun 2025
I focus on the power of compounding—both in life and investing—and recommend a slow, steady approach to building wealth. My top five monthly dividend REIT picks are Realty Income, LTC Properties,
Agree Realty: Add The King Of Retail REITs To Your Portfolio
04:33pm, Tuesday, 10'th Jun 2025
Agree Realty Corporation is a net lease real estate investment trust, with a top tier retailer tenant list. ADC consistently outperforms the real estate sector indexes, paying a consistent monthly div
Agree Realty Declares Monthly Common and Preferred Dividends
04:05pm, Tuesday, 10'th Jun 2025
ROYAL OAK, Mich. , June 10, 2025 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced that its Board of Directors has authorized, and the Company has declared, a monthl
Agree Realty: Crown Jewel Of My REIT Portfolio On Hold
06:17am, Tuesday, 10'th Jun 2025
Agree Realty consistently outperforms peers with strong AFFO growth, top-tier tenant quality, and a robust, defensive portfolio. The REIT boasts high investment-grade tenant exposure (68.3%), excellen
Agree Realty Is Ready For The Next Market Shift
08:55am, Monday, 09'th Jun 2025
Agree Realty is a defensive, growth-oriented REIT, thriving despite market volatility by focusing on essential, e-commerce-resistant tenants and disciplined portfolio management. ADC's record investme
Defence Therapeutics Receives USPTO Allowance for Patent Application Covering Next-Gen ADC Technology
03:15am, Monday, 09'th Jun 2025
Montreal, Quebec--(Newsfile Corp. - June 9, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in drug
3 Top Real Estate Dividend Stocks to Buy for Super Easy Passive Income in June
09:12pm, Tuesday, 03'rd Jun 2025
Investing in real estate can be a great way to make passive income. There are lots of options, including buying a rental property.
SAN FRANCISCO and SUZHOU, China , June 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commerciali
SAN FRANCISCO and SUZHOU, China , June 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercial
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
04:05pm, Monday, 02'nd Jun 2025
LAUSANNE, Switzerland , June 2, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced tha
